AP

Alok Pathak

Active Director Director DIN 09516557
DIN 09516557 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Alok Pathak

Data last updated:

Alok Pathak is a Director at Yaxon Bio Care Private Limited (since 2022). The company operates in Pharma. Yaxon Bio Care Private Limited reported revenue of ₹11.57 Cr (FY 2025).

DIN 09516557
Primary Designation Director
Industry Pharma
First Appointment 24 Feb 2022
Oldest Company Age 15 yrs
Largest company Yaxon Bio Care Private Limited · ₹11.57 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yaxon Bio Care Private Limited U74140DL2011PTC219437
Director24 Feb 20222011₹11.57 Cr (FY 2025)Active

Board colleagues of Alok Pathak

Directorship timeline

Open interactive timeline →
Yaxon Bio Care Private Limited
Premium access

Shareholding and investment profile for Alok Pathak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alok Pathak

Alok Pathak currently holds 1 directorship: Yaxon Bio Care Private Limited (Director, since 24 Feb 2022, revenue ₹11.57 Cr (FY 2025)).

Alok Pathak was first appointed on 24 Feb 2022 as Director at Yaxon Bio Care Private Limited.

The current boards of Alok Pathak's companies include Chiranjeev Singh Cheema (Yaxon Bio Care Private Limited), Nitin Arneja (Yaxon Bio Care Private Limited), Vipin Satija (Yaxon Bio Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available